Cargando…
Development and Characterization of High-Throughput Caenorhabditis elegans – Enterococcus faecium Infection Model
The genus Enterococcus includes two Gram-positive pathogens of particular clinical relevance: E. faecalis and E. faecium. Infections with each of these pathogens are becoming more frequent, particularly in the case of hospital-acquired infections. Like most other bacterial species of clinical import...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116795/ https://www.ncbi.nlm.nih.gov/pubmed/33996637 http://dx.doi.org/10.3389/fcimb.2021.667327 |
_version_ | 1783691472972808192 |
---|---|
author | Revtovich, Alexey V. Tjahjono, Elissa Singh, Kavindra V. Hanson, Blake M. Murray, Barbara E. Kirienko, Natalia V. |
author_facet | Revtovich, Alexey V. Tjahjono, Elissa Singh, Kavindra V. Hanson, Blake M. Murray, Barbara E. Kirienko, Natalia V. |
author_sort | Revtovich, Alexey V. |
collection | PubMed |
description | The genus Enterococcus includes two Gram-positive pathogens of particular clinical relevance: E. faecalis and E. faecium. Infections with each of these pathogens are becoming more frequent, particularly in the case of hospital-acquired infections. Like most other bacterial species of clinical importance, antimicrobial resistance (and, specifically, multi-drug resistance) is an increasing threat, with both species considered to be of particular importance by the World Health Organization and the US Centers for Disease Control. The threat of antimicrobial resistance is exacerbated by the staggering difference in the speeds of development for the discovery and development of the antimicrobials versus resistance mechanisms. In the search for alternative strategies, modulation of host-pathogen interactions in general, and virulence inhibition in particular, have drawn substantial attention. Unfortunately, these approaches require a fairly comprehensive understanding of virulence determinants. This requirement is complicated by the fact that enterococcal infection models generally require vertebrates, making them slow, expensive, and ethically problematic, particularly when considering the thousands of animals that would be needed for the early stages of experimentation. To address this problem, we developed the first high-throughput C. elegans–E. faecium infection model involving host death. Importantly, this model recapitulates many key aspects of murine peritonitis models, including utilizing similar virulence determinants. Additionally, host death is independent of peroxide production, unlike other E. faecium–C. elegans virulence models, which allows the assessment of other virulence factors. Using this system, we analyzed a panel of lab strains with deletions of targeted virulence factors. Although removal of certain virulence factors (e.g., Δfms15) was sufficient to affect virulence, multiple deletions were generally required to affect pathogenesis, suggesting that host-pathogen interactions are multifactorial. These data were corroborated by genomic analysis of selected isolates with high and low levels of virulence. We anticipate that this platform will be useful for identifying new treatments for E. faecium infection. |
format | Online Article Text |
id | pubmed-8116795 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81167952021-05-14 Development and Characterization of High-Throughput Caenorhabditis elegans – Enterococcus faecium Infection Model Revtovich, Alexey V. Tjahjono, Elissa Singh, Kavindra V. Hanson, Blake M. Murray, Barbara E. Kirienko, Natalia V. Front Cell Infect Microbiol Cellular and Infection Microbiology The genus Enterococcus includes two Gram-positive pathogens of particular clinical relevance: E. faecalis and E. faecium. Infections with each of these pathogens are becoming more frequent, particularly in the case of hospital-acquired infections. Like most other bacterial species of clinical importance, antimicrobial resistance (and, specifically, multi-drug resistance) is an increasing threat, with both species considered to be of particular importance by the World Health Organization and the US Centers for Disease Control. The threat of antimicrobial resistance is exacerbated by the staggering difference in the speeds of development for the discovery and development of the antimicrobials versus resistance mechanisms. In the search for alternative strategies, modulation of host-pathogen interactions in general, and virulence inhibition in particular, have drawn substantial attention. Unfortunately, these approaches require a fairly comprehensive understanding of virulence determinants. This requirement is complicated by the fact that enterococcal infection models generally require vertebrates, making them slow, expensive, and ethically problematic, particularly when considering the thousands of animals that would be needed for the early stages of experimentation. To address this problem, we developed the first high-throughput C. elegans–E. faecium infection model involving host death. Importantly, this model recapitulates many key aspects of murine peritonitis models, including utilizing similar virulence determinants. Additionally, host death is independent of peroxide production, unlike other E. faecium–C. elegans virulence models, which allows the assessment of other virulence factors. Using this system, we analyzed a panel of lab strains with deletions of targeted virulence factors. Although removal of certain virulence factors (e.g., Δfms15) was sufficient to affect virulence, multiple deletions were generally required to affect pathogenesis, suggesting that host-pathogen interactions are multifactorial. These data were corroborated by genomic analysis of selected isolates with high and low levels of virulence. We anticipate that this platform will be useful for identifying new treatments for E. faecium infection. Frontiers Media S.A. 2021-04-29 /pmc/articles/PMC8116795/ /pubmed/33996637 http://dx.doi.org/10.3389/fcimb.2021.667327 Text en Copyright © 2021 Revtovich, Tjahjono, Singh, Hanson, Murray and Kirienko https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cellular and Infection Microbiology Revtovich, Alexey V. Tjahjono, Elissa Singh, Kavindra V. Hanson, Blake M. Murray, Barbara E. Kirienko, Natalia V. Development and Characterization of High-Throughput Caenorhabditis elegans – Enterococcus faecium Infection Model |
title | Development and Characterization of High-Throughput Caenorhabditis elegans – Enterococcus faecium Infection Model |
title_full | Development and Characterization of High-Throughput Caenorhabditis elegans – Enterococcus faecium Infection Model |
title_fullStr | Development and Characterization of High-Throughput Caenorhabditis elegans – Enterococcus faecium Infection Model |
title_full_unstemmed | Development and Characterization of High-Throughput Caenorhabditis elegans – Enterococcus faecium Infection Model |
title_short | Development and Characterization of High-Throughput Caenorhabditis elegans – Enterococcus faecium Infection Model |
title_sort | development and characterization of high-throughput caenorhabditis elegans – enterococcus faecium infection model |
topic | Cellular and Infection Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116795/ https://www.ncbi.nlm.nih.gov/pubmed/33996637 http://dx.doi.org/10.3389/fcimb.2021.667327 |
work_keys_str_mv | AT revtovichalexeyv developmentandcharacterizationofhighthroughputcaenorhabditiselegansenterococcusfaeciuminfectionmodel AT tjahjonoelissa developmentandcharacterizationofhighthroughputcaenorhabditiselegansenterococcusfaeciuminfectionmodel AT singhkavindrav developmentandcharacterizationofhighthroughputcaenorhabditiselegansenterococcusfaeciuminfectionmodel AT hansonblakem developmentandcharacterizationofhighthroughputcaenorhabditiselegansenterococcusfaeciuminfectionmodel AT murraybarbarae developmentandcharacterizationofhighthroughputcaenorhabditiselegansenterococcusfaeciuminfectionmodel AT kirienkonataliav developmentandcharacterizationofhighthroughputcaenorhabditiselegansenterococcusfaeciuminfectionmodel |